Cargando…
Science and Decisions: Advancing Toxicology to Advance Risk Assessment
In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537122/ https://www.ncbi.nlm.nih.gov/pubmed/22874419 http://dx.doi.org/10.1093/toxsci/kfs246 |
_version_ | 1782254841758744576 |
---|---|
author | Rodricks, Joseph V. Levy, Jonathan I. |
author_facet | Rodricks, Joseph V. Levy, Jonathan I. |
author_sort | Rodricks, Joseph V. |
collection | PubMed |
description | In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environmental Protection Agency that could both influence and be influenced by evolving toxicological practice. In particular, Science and Decisions emphasized the scientific and operational necessity of a new approach for dose-response modeling; addressed the recurring challenge of defaults in risk assessment and the question of when research results can be used in place of defaults; and reinforced the value of cumulative risk assessment, which would require enhanced understanding of the joint influence of chemical and nonchemical stressors on health outcomes. The objective of this article is to summarize key messages from Science and Decisions, both as a stand-alone report and in comparison with another recent NRC report, Toxicity Testing in the 21st Century: A Vision and a Strategy. Although these reports have many conclusions in common and reinforce similar themes, there are important differences that merit careful consideration, such as the move away from apical endpoints in Toxicity Testing and the emphasis on benefit-cost analyses and related decision tools in Science and Decisions that would be strengthened by quantification of apical endpoints. Moving risk assessment forward will require toxicologists to wrestle with the implications of Science and Decisions from a toxicological perspective. |
format | Online Article Text |
id | pubmed-3537122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35371222013-01-04 Science and Decisions: Advancing Toxicology to Advance Risk Assessment Rodricks, Joseph V. Levy, Jonathan I. Toxicol Sci Forum In 2009, the National Research Council (NRC) released the latest in a series of advisory reports on human health risk assessment, titled Science and Decisions: Advancing Risk Assessment. This wide-ranging report made a number of recommendations related to risk assessment practice at the U.S. Environmental Protection Agency that could both influence and be influenced by evolving toxicological practice. In particular, Science and Decisions emphasized the scientific and operational necessity of a new approach for dose-response modeling; addressed the recurring challenge of defaults in risk assessment and the question of when research results can be used in place of defaults; and reinforced the value of cumulative risk assessment, which would require enhanced understanding of the joint influence of chemical and nonchemical stressors on health outcomes. The objective of this article is to summarize key messages from Science and Decisions, both as a stand-alone report and in comparison with another recent NRC report, Toxicity Testing in the 21st Century: A Vision and a Strategy. Although these reports have many conclusions in common and reinforce similar themes, there are important differences that merit careful consideration, such as the move away from apical endpoints in Toxicity Testing and the emphasis on benefit-cost analyses and related decision tools in Science and Decisions that would be strengthened by quantification of apical endpoints. Moving risk assessment forward will require toxicologists to wrestle with the implications of Science and Decisions from a toxicological perspective. Oxford University Press 2013-01 2012-08-08 /pmc/articles/PMC3537122/ /pubmed/22874419 http://dx.doi.org/10.1093/toxsci/kfs246 Text en © The Author 2012. Published by Oxford University Press on behalf of the Society of Toxicology. For permissions, please email: journals.permissions@oup.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Forum Rodricks, Joseph V. Levy, Jonathan I. Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title | Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title_full | Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title_fullStr | Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title_full_unstemmed | Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title_short | Science and Decisions: Advancing Toxicology to Advance Risk Assessment |
title_sort | science and decisions: advancing toxicology to advance risk assessment |
topic | Forum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537122/ https://www.ncbi.nlm.nih.gov/pubmed/22874419 http://dx.doi.org/10.1093/toxsci/kfs246 |
work_keys_str_mv | AT rodricksjosephv scienceanddecisionsadvancingtoxicologytoadvanceriskassessment AT levyjonathani scienceanddecisionsadvancingtoxicologytoadvanceriskassessment |